[Inhibition of VSMC proliferation by nitric oxide].
Sato
Ryuji
R
Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School.
Hirata
Yukio
Y
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D001161:Arteriosclerosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D002455:Cell Division / Q000187:drug effects* / Q000235:genetics; D006152:Cyclic GMP; D003864:Depression, Chemical; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D009569:Nitric Oxide / Q000494:pharmacology* / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000502:physiology; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III
D009569:Nitric Oxide; C496319:NOS2 protein, human; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D006152:Cyclic GMP